Sequoia Vaccines, Inc. (SQVI)
Sequoia Vaccines will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$8.00 - $10.00
Shares Offered
2,775,000
Deal Size
$24.98M
Sequoia Vaccines Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
79.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSQVI News
- 1 year ago - U.S. IPO Weekly Recap: Reinsurance And CAR T Therapies Lead A 3 IPO Week - Seeking Alpha
- 1 year ago - Sequoia Vaccines Begins $20 Million IPO Effort - Seeking Alpha
- 1 year ago - Vaccine developer Sequoia Vaccines files for a $20 million IPO - Renaissance Capital
- 1 year ago - Sequoia Vaccines IPO Registration Document (S-1) - SEC